A Phase 1 Study Investigating the Pharmacokinetics of FV-100 With and Without Ritonavir in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 03 Mar 2016
At a glance
- Drugs Valnivudine (Primary) ; Ritonavir
- Indications Herpes zoster
- Focus Adverse reactions; Pharmacokinetics
- Sponsors ContraVir Pharmaceuticals
- 03 Mar 2016 Results published in a ContraVir Pharmaceuticals media release.
- 30 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Feb 2015 Status changed from not yet recruiting to recruiting, according to a ContraVir Pharmaceuticals media release.